CHEMICAL AND PHYSICAL PROPERTIES
| Melting Point | 200-216 |
|---|---|
| Solubility | Practically insoluble |
COMPUTED DESCRIPTORS
| Molecular Weight | 428.9 g/mol |
|---|---|
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 2 |
| Exact Mass | 428.1565934 g/mol |
| Monoisotopic Mass | 428.1565934 g/mol |
| Topological Polar Surface Area | 74.6 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 843 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Ulobetasol is a highly potent corticosteroid. It is structurally related to [clobetasol]. Due to its high potency, it is mainly prescribed in the treatment of severe plaque psoriasis and corticosteroid responsive dermatoses. Ulobetasol was granted FDA approval on 17 December 1990.